The Prognostic Significance of Thymidine Kinase Activity Levels In Metastatic Colorectal Cancer

The Prognostic Significance of Thymidine Kinase Activity Levels In Metastatic Colorectal Cancer

Aim:Serum thymidine kinase 1 (TK1) is a sensitive marker of tumor cell proliferation.In this study we aimed to investigate the prognostic significance of serum TK1 activity in metastatic colorectal cancer (MCRC) patients receiving palliative chemotherapy.Materials and Methods:We prospectively measur...

Full description

Bibliographic Details
Main Author:	Erdoğan Selçuk ŞEBER
Format:	Article
Language:	English
Published:	Galenos Yayincilik 2016-12-01
Series:	Namık Kemal Tıp Dergisi
Subjects:	metastatic colorectal cancer chemotherapy progression free survival overall survival thymidine kinase
Online Access:	http://namikkemalmedj.com/archives/archive-detail/article-preview/the-prognostic-significance-of-thymidine-kinase-ac/40435

Similar Items

The impact of combining cetuximab with the traditional chemotherapy regimens on clinical effectiveness in metastatic colorectal cancer: a systematic review and meta-analysis
by: Marryam Azeem, et al.
Published: (2025-02-01)

Treatment Outcomes of Metastatic Colorectal Cancer Patients Treated with Regorafenib as Third-Line Setting-A Multicenter Study
by: Süleyman Şahin, et al.
Published: (2019-03-01)

Rechallenge therapy versus tyrosine kinase inhibitor (TKI) for advanced metastatic colorectal cancer: a retrospective study
by: Chenming Liu, et al.
Published: (2025-02-01)

Elevated Levels of Serum Thymidine Kinase 1 Predict Poor Survival for Patients with Metastatic Prostate Cancer
by: Teemu J. Murtola, et al.
Published: (2024-12-01)

Meeting An Unmet Need in Metastatic Colorectal Carcinoma with Regorafenib
by: Barbara Melosky
Published: (2016-01-01)

Treatment outcomes of advanced/metastatic extramammary Paget's disease in Korean patients: KCSG‐RC20‐06
by: Byeong Seok Sohn, et al.
Published: (2023-07-01)

Incidence and prognostic factors in patents (pts) with mutant BRAF (mBRAF) metastatic colorectal cancer (mCRC) in Russia
by: M. Yu. Fedyanin, et al.
Published: (2021-06-01)

Circulating vitamin D level before initiating chemotherapy impacts on the time-to-outcome in metastatic colorectal cancer patients: systematic review and meta-analysis
by: Alessandro Ottaiano, et al.
Published: (2024-01-01)

Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study
by: Sabin Goktas Aydin, et al.
Published: (2023-11-01)

The Role of Circulating Tumor Cells in the Prognosis of Metastatic Triple-Negative Breast Cancers: A Systematic Review of the Literature
by: Lorena Alexandra Lisencu, et al.
Published: (2022-03-01)

Optimal duration of a first-line palliative chemotherapy in disseminated colorectal cancer – a review of the literature from a developing country perspective
by: Wojciech Rogowski, et al.
Published: (2016-08-01)

MiRNA expression affects survival in patients with obstructive sleep apnea and metastatic colorectal cancer
by: Piera Soccio, et al.
Published: (2025-02-01)

Early discontinuation of immune checkpoint inhibitor therapy prior to disease progression in patients with metastatic non-small cell lung cancer: a survival analysis
by: Blake J. McKinley, et al.
Published: (2024-06-01)

Serum creatinine/cystatin C ratio as a prognostic indicator for patients with colorectal cancer
by: Shunhui Gao, et al.
Published: (2023-06-01)

Association of thymidine kinase-1 with prostate cancer
by: Changyi Jiang, et al.
Published: (2024-02-01)

Impact of Surgery and Chemotherapy on Metastatic Extrauterine Leiomyosarcoma
by: Yoshinori Imura, et al.
Published: (2022-03-01)

Clinical outcomes of abiraterone acetate and predictors of its treatment duration in metastatic castration‐resistant prostate cancer: Real‐world experience in the Southeast Asian cohort
by: Jasmine Lim, et al.
Published: (2020-07-01)

Quantifying the impact of novel metastatic cancer therapies on health inequalities in survival outcomes
by: Karolina Zebrowska, et al.
Published: (2023-11-01)

Contextualizing Olaparib and Abiraterone in the Current Treatment Landscape for Metastatic Castration-resistant Prostate Cancer
by: Giuseppe Fallara, et al.
Published: (2023-06-01)

Serum concentrations of Thymidine kinase 1 measured using a novel antibody-based assay in patients with Hodgkin Lymphoma
by: Johan Mattsson Ulfstedt, et al.
Published: (2021-08-01)

Real-world treatment patterns and clinical outcomes for chemotherapy-based regimens in first-line MSI-H/dMMR metastatic colorectal cancer
by: Mayur M. Amonkar, et al.
Published: (2023-01-01)

Potential impact of platelet-to-lymphocyte ratio on prognosis in patients with colorectal cancer: A systematic review and meta-analysis
by: Ganlin Guo, et al.
Published: (2023-03-01)

Treatment Outcomes of HER-2 Positive Metastatic Breast Cancer Patients Treated with Pertuzumab in the First Line Setting- Real Life Experience
by: Bekir Hacioglu, et al.
Published: (2019-04-01)

Efficacy of adjuvant chemotherapy after curative hepatectomy for patients with colorectal cancer liver metastases: a single-center retrospective study
by: Akira Inoue, et al.
Published: (2024-12-01)

Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency
by: Caterina Garone, et al.
Published: (2014-06-01)

Survival analysis for complicated colorectal cancer
by: S. N. Schaeva
Published: (2017-09-01)

Real-World Study to Assess Patterns of Treatment Practices and Clinical Outcomes in Metastatic Colorectal Cancer Patients with <i>RAS</i> Wild-Type Left-Sided Tumours in Canada
by: Devon J. Boyne, et al.
Published: (2023-09-01)

Analysis of the efficacy and tolerability of FOLFIRINOX chemotherapy treatment in patients over 65 years of age with diagnosis of advanced adenocarcinoma of the pancreas
by: Małgorzata Domagała-Haduch, et al.
Published: (2023-04-01)

Role of Serum CYFRA 21-1 in Diagnosis and Prognostic in Colorectal Liver Metastases
by: Li S, et al.
Published: (2023-07-01)

An Adenovirus Vector Containing the Suicide Gene Thymidine Kinase for a Broad Application in Cancer Gene Therapy
by: GS Magalhães, et al.
Published: (2002-06-01)

Overall survival with non-proportional hazards in first-line treatment for patients with metastatic colorectal cancer: Systematic review and network meta-analysis
by: Fatemeh Keshavarzi, et al.
Published: (2024-08-01)

Prognostic significance of programmed cell death 1 expression on CD8+T cells in various cancers: a systematic review and meta-analysis
by: Zhiyong Wan, et al.
Published: (2025-01-01)

Correlation between spleen density and prognostic outcomes in patients with colorectal cancer after curative resection
by: Yunzhou Xiao, et al.
Published: (2024-04-01)

Clinical and prognostic significance of Hec1 expression in patients with Cervical Cancer
by: Yutai Zhao, et al.
Published: (2024-10-01)

METASTASIS OF BREAST CANCER IN THE OVARIES. SURVIVAL AND PROGNOSTIC FACTORS
by: S. N. Tadzhibov, et al.
Published: (2017-06-01)

Extended Survival and Prognostic Factors in Endometrial Cancer: A Multivariate Cox Regression Analysis
by: Irene Valencia Téllez, et al.
Published: (2024-12-01)

Prognostic value of the pretreatment Naples prognostic score in patients with colorectal cancer: a systematic review and meta-analysis
by: Hui Liu, et al.
Published: (2025-01-01)

Survival comparison of first-line treatment regimens in patients with braf-mutated advanced colorectal cancer: a multicenter retrospective study
by: Qianhao Meng, et al.
Published: (2023-02-01)

Immunotherapy plus chemotherapy versus chemotherapy alone in the first-line treatment for advanced gastric cancer/gastroesophageal junction cancer: a real-world retrospective study
by: Qian Xu, et al.
Published: (2024-11-01)

Nomograms integrating CT radiomic and deep learning signatures to predict overall survival and progression-free survival in NSCLC patients treated with chemotherapy
by: Runsheng Chang, et al.
Published: (2023-10-01)